Preview

Пульмонология

Расширенный поиск

Нозокомиальная пневмония у взрослых: практические рекомендации по диагностике, лечению и профилактике. Пособие для врачей

https://doi.org/10.18093/0869-0189-2005-0-3-13-36

Полный текст:

Об авторах

А. Г. Чучалин
Российское респираторное общество; Межрегиональная ассоциация по клинической микробиологии и антимикробной химиотерапии (МАКМАХ); Федерация анестезиологов и реаниматологов России
Россия


А. И. Синопальников
Российское респираторное общество; Межрегиональная ассоциация по клинической микробиологии и антимикробной химиотерапии (МАКМАХ); Федерация анестезиологов и реаниматологов России
Россия


Л. С. Страчунский
Российское респираторное общество; Межрегиональная ассоциация по клинической микробиологии и антимикробной химиотерапии (МАКМАХ); Федерация анестезиологов и реаниматологов России
Россия


Р. С. Козлов
Российское респираторное общество; Межрегиональная ассоциация по клинической микробиологии и антимикробной химиотерапии (МАКМАХ); Федерация анестезиологов и реаниматологов России
Россия


В. А. Руднов
Российское респираторное общество; Межрегиональная ассоциация по клинической микробиологии и антимикробной химиотерапии (МАКМАХ); Федерация анестезиологов и реаниматологов России
Россия


С. В. Яковлев
Российское респираторное общество; Межрегиональная ассоциация по клинической микробиологии и антимикробной химиотерапии (МАКМАХ); Федерация анестезиологов и реаниматологов России
Россия


О. У. Стецюк
Российское респираторное общество; Межрегиональная ассоциация по клинической микробиологии и антимикробной химиотерапии (МАКМАХ); Федерация анестезиологов и реаниматологов России
Россия


Г. К. Решедько
Российское респираторное общество; Межрегиональная ассоциация по клинической микробиологии и антимикробной химиотерапии (МАКМАХ); Федерация анестезиологов и реаниматологов России
Россия


Список литературы

1. Tablan О.С., Anderson L.J., Besser R. et al. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee: guidelines for preventing health-care-associated pneumonia, 2003. Mortal. Morbid. Wkly Rep. 2004; 53 (RR-3): 1–36.

2. Hospital-acquired Pneumonia Guideline Committee of the American Thoracic Society & Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired pneumonia, ventilator-associated pneumonia, and healthcare-associated pneumonia — 2005. Am. J. Respir. Crit. Care Med. 2005. (In press).

3. Craven D.E., Palladino R., McQuillen D.P. Healthcare-associated pneumonia in adults: management principles to improve outcomes. Infect. Dis. Clin. N. Am. 2004; 18: 939–962.

4. American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am. J. Respir. Crit. Care Med. 2001; 163: 1730–1754.

5. Kollef M.H. Prevention of hospital-associated pneumonia and ventilator-associated pneumonia. Crit. Care Med. 2004; 32: 1396–1405.

6. Гельфанд Б.Р., Белоцерковский Б.З., Проценко Д.Н. Нозокомиальная пневмония в хирургии: Метод. рекомендации РАСХИ. М.; 2003.

7. Fabregas N., Ewig S., Torres A. et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 1999; 54: 867–873.

8. Heyland D.K., Cook D.J., Griffith L., et al. The attributable morbidity and mortality of ventilator-associated pneumonia in critically ill patients. Am. J. Respir. Crit. Care Med. 1999; 159: 1249–1256.

9. Rello J., Ollendorf D.A., Oster C. et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002; 122: 2115–2121.

10. Kollef M.H. The importance of appropriate initial antibiotic therapy for hospital-acquired infections. Am. J. Med. 2003; 115: 582–584.

11. Hubmayr R.D. Statement of the 4th International Consensus Conference in Critical Care in ICU-Acquired Pneumonia, Illinois, May, 2002. Intensive Care Med. 2002; 28: 1521–1536.

12. Sirvent J.M., Torres A., Vidaur L. et al. Tracheal colonisation within 24-h of intubation in patients with head trauma: risk factor for developing early-onset ventilator-associated pneumonia. Intensive Care Med. 2000; 26: 1369–1372.

13. Drakulovic M.B., Torres A., Bauer T.T. et al. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 1999; 354: 1851–1858.

14. Ibrahim E.H., Mehringer L., Prentice D. et al. Early versus late enteral feeding of mechanically ventilated patients: results of a clinical trial. J. Parenter. Enter. Nutr. 2002; 26: 174–181.

15. Craven D.E., Driks M.R. Nosocomial pneumonia in the intubated patient. Semin. Respir. Infect. 1987; 2: 20–33.

16. Heyland D.K., Drover G.W., MacDonald S. et al. Effect of postpyloric feeding on gastroesophageal regurgitation and pulmonary microaspiration: Results of a randomized controlled trial. Crit. Care Med. 2001; 29: 1495–1501.

17. Pugin J., Auckenthaler R., Mili N. et al. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic blind broncho-alveolar lavage fluid. Am. Rev. Respir. Dis. 1991; 143: 1121–1129.

18. Luna C.M., Videla A., Mattera J. et al. Blood cultures have limited value in predicting severity of illness and as a diagnostic tool in ventilator-associated pneumonia. Chest 1999; 116: 1075–1084.

19. Fagon J.Y., Chastre J., Wolff M. et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann. Intern. Med. 2000; 132: 621–630.

20. Cook D., Mandell L. Endotracheal aspiration in the diagnosis of ventilator-associated pneumonia. Chest 2000; 117: 195S–197S.

21. Campbell G.D. Blinded invasive diagnostic procedures in ventilator-associated pneumonia. Chest 2000; 117: 207S–211S.

22. Shorr A.F., Sherner J.H., Jackson W.L., Kollef M.H. Invasive approaches to diagnosis of ventilator-associated pneumonia: A meta-analysis. Crit. Care Med. 2005; 33: 46–53.

23. Определение чувствительности микроорганизмов к антибактериальным препаратам. (Методические указания МУК 4.2.1890-04.) Клин. микробиол. антимикроб. химиотер 2004; 6: 306–359

24. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification system. Crit. Care Med. 1985; 13: 818–829.

25. Teasdale C., Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974; 2: 81–83.

26. Kollef M.H., Scherman G., Want S. et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115: 462–474.

27. Kollef M.H. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin. Infect. Dis. 2000; 31 (suppl. 4): S131–S138.

28. Alwarez1Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in Intensive Care Unit: ICU Acquired Pneumonia Study Group. Intensive Care Med. 1996; 22: 387–394.

29. Iregui M., Ward S., Sherman G. et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest. 2002; 122: 262–268.

30. Niederman M.S. Therapy of ventilator-associated pneumonia: What more can we do to use less antibiotics? Crit. Care Med. 2004; 32: 2344–2345.

31. Cometta A.J., Baumgartner D., Lew D., et al. Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients. Antimicrob. Agents. Chemother. 1994; 38: 1309–1313.

32. Paul M., Benuri1Silbiger I., Soares1Weiser K. et al. Beta-lactam monotherapy versus beta-lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomized trials. Br. Med. J. 2004; 328: 668.

33. Singh N., Rogers P., Atwood C.W. et al. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. Am. J. Respir. Crit. Care Med. 2000; 162: 505–511.

34. Luna C.M., Blanzaco D., Niederman M.S. et al. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit. Care Med. 2003; 31:676–682.

35. Dennesen P.J., Van der Ven A.J., Kessels A.G. et al. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 2001; 163: 1371–1375.

36. Chastre J., Wolff M., Fagon J.1Y. et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults. A randomized trial. J.A.M.A. 2003; 290: 2588–2598.

37. Micek S.T., Ward S., Fraser V.J. et al. A randomized controlled trial of antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 2004; 125: 1791–1799.

38. Hoffken G., Niederman M.S. Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest 2002; 122: 2183–2196.

39. Rello J., Vidaur L., Sandiumenge A. et al. De-escalation therapy in ventilator-associated pneumonia. Crit. Care Med. 2004; 32: 2183–2190.

40. Ibrahim E.H., Ward S., Sherman G. et al. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit. Care Med. 2001; 29: 1109–1115.

41. Kollef M.H. Niederman M.S., Leeper K.V. et al. Escalation / de-escalation of initial empiric ventilator-associated pneumonia therapy: interim results from the assessment of local antimicrobial resistance measures study. Chest 2004; 126 (suppl. 4): 717S.

42. Orozco1Levi M., Torres A., Ferrer M. et al. Semirecumbent position protects from pulmonary aspiration but not completely from gastroesophageal reflux in mechanically ventilated patients. Am. J. Respir. Crit. Care Med. 1995; 152: 1387–1390.

43. Torres A., Serra1Batlles J., Ros E. et al. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann. Intern. Med. 1992; 116: 540–543.

44. Wenzel R., Brewer T., Butzler J.1P., eds. BC A guide to infection control in the hospital. 2-nd ed. London: BC Decker Inc.; 2002.

45. Koeman M., Van der Ven A.J.A., Hoepelman I.M. et al. Oropharyngeal decontamination with chlorhexidine gluconate-2%, with or without colistin, reduces the incidence of ventilator-associated pneumonia: a randomized double-blind, placebo-controlled, multi center study. In: 44-th ICAAC. Washington; 2004. Abstr. 3717.


Для цитирования:


Чучалин А.Г., Синопальников А.И., Страчунский Л.С., Козлов Р.С., Руднов В.А., Яковлев С.В., Стецюк О.У., Решедько Г.К. Нозокомиальная пневмония у взрослых: практические рекомендации по диагностике, лечению и профилактике. Пособие для врачей. Пульмонология. 2005;(3):13-36. https://doi.org/10.18093/0869-0189-2005-0-3-13-36

For citation:


Chuchalin A.G., Sinopalnikov A.I., Strachunsky L.S., Kozlov R.S., Rudnov V.A., Yakovlev S.V., Stetsyuk O.U., Reshedko G.K. Nosocomial pneumonia in adults: practical recommendations on diagnosis, treatment and prevention. Medical supplementation. PULMONOLOGIYA. 2005;(3):13-36. (In Russ.) https://doi.org/10.18093/0869-0189-2005-0-3-13-36

Просмотров: 15


ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)